Literature DB >> 18811886

Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF.

Shouchun Peng1, Zhenhua Li, Jian Kang, Xianming Hou.   

Abstract

BACKGROUND AND
OBJECTIVE: This study was performed to confirm the cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire (SGRQ) for the measurement of health-related quality of life (HRQoL) in patients with IPF.
METHODS: Sixty-eight patients with IPF responded to the SGRQ and pulmonary function tests (PFT), dyspnoea testing, arterial blood gas analysis, 6-min walk tests (6MWT) and high-resolution computed tomography were performed in a baseline study. A follow-up study was performed on 45 of these patients.
RESULTS: In the baseline study HRQoL as measured by the SGRQ was substantially impaired in IPF patients, especially in symptoms and activity domains. A significant decline in HRQoL was observed in the activity domain during follow up. TLC and changes in TLC showed the most significant inverse correlations with each SGRQ domain (r < -0.3, P < 0.05). In a stepwise multiple regression analysis, TLC contributed most significantly to each SGRQ component baseline score. Similar results were also observed during follow up. There was a significant correlation between total CT scores and each component of the SGRQ (r > 0.3, P < or = 0.001). Changes in ground-glass opacity on CT (CT-alv) were also correlated with changes in each SGRQ domain (r > 0.3, P < or = 0.001). Stepwise multiple regression analysis showed that interstitial opacity on CT (CT-fib) contributed to variation in the baseline activity score, and that changes in CT-alv independently contributed to overall changes in the SGRQ domains during follow up. The dyspnoea score, and changes in the dyspnoea score, correlated significantly with the SGRQ sores, with the exception of the symptoms score, in both the baseline and follow-up studies.
CONCLUSIONS: HRQoL as assessed by the SGRQ showed good cross-sectional and longitudinal construct validity in patients with IPF. However, additional studies are required to analyse the reliability and responsiveness so that the SGRQ can be used in patients with IPF.

Entities:  

Mesh:

Year:  2008        PMID: 18811886     DOI: 10.1111/j.1440-1843.2008.01359.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

1.  Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.

Authors:  Monique Wapenaar; Amit S Patel; Surinder S Birring; Ron T van Domburg; Eric Wp Bakker; Virginia Vindigni; C Magnus Sköld; Vincent Cottin; Carlo Vancheri; Marlies S Wijsenbeek
Journal:  Chron Respir Dis       Date:  2016-12-26       Impact factor: 2.444

2.  Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.

Authors:  Baruch Vainshelboim; Jose Oliveira; Benjamin Daniel Fox; Yafit Soreck; Oren Fruchter; Mordechai Reuven Kramer
Journal:  Lung       Date:  2015-03-03       Impact factor: 2.584

Review 3.  The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review.

Authors:  Jeffrey J Swigris; Dirk Esser; Craig S Conoscenti; Kevin K Brown
Journal:  Health Qual Life Outcomes       Date:  2014-08-20       Impact factor: 3.186

Review 4.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17

5.  Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Authors:  Michael Kreuter; Jeff Swigris; David Pittrow; Silke Geier; Jens Klotsche; Antje Prasse; Hubert Wirtz; Dirk Koschel; Stefan Andreas; Martin Claussen; Christian Grohé; Henrike Wilkens; Lars Hagmeyer; Dirk Skowasch; Joachim F Meyer; Joachim Kirschner; Sven Gläser; Felix J F Herth; Tobias Welte; Claus Neurohr; Martin Schwaiblmair; Matthias Held; Thomas Bahmer; Marion Frankenberger; Jürgen Behr
Journal:  Respir Res       Date:  2017-07-14

6.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

7.  The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.

Authors:  Sokai Akihiko; Handa Tomohiro; Oga Toru; Tanizawa Kiminobu; Ikezoe Kohei; Nakatsuka Yoshinari; Kubo Takeshi; Kanatani Kumiko; Chin Kazuo; Mishima Michiaki
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

8.  Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15).

Authors:  Yoshinobu Matsuda; Tatsuya Morita; Shunsuke Oyamada; Keisuke Ariyoshi; Takuhiro Yamaguchi; Satoru Iwase
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

9.  Validation of the Saint George's Respiratory Questionnaire in Uganda.

Authors:  Brooks W Morgan; Matthew R Grigsby; Trishul Siddharthan; Robert Kalyesubula; Robert A Wise; John R Hurst; Bruce Kirenga; William Checkley
Journal:  BMJ Open Respir Res       Date:  2018-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.